Tuesday, March 03, 2015 8:16:02 PM
When performing an analysis of an OTC company, most areas of discussion are highly subjective. Since this is the case, any objective measures that exist become critically important in the overall assessment of future potential.
Here's an objective evaluation of one of the most success determinant measures for an OTC company... the growth of the common shares outstanding since inception.
'On February 25, 2014, control of the Company was transferred from Gregory Lykiardopoulos to Green Cures, Inc., a California corporation, pursuant to a Stock Purchase Agreement entered on February 5,2014.'
There have been three quarterly filings, since Green Cures took over the ticker (the qtrs ended March, June and September). The total common shares outstanding, reported on these filings, is detailed below.
Total common shares outstanding: 1,633,695,597 as of: 4/23/14 (filing for the quarter ended 3/31/2014, filed on 5/15/2014)
Total common shares outstanding: 1,636,233,097 as of: 07/28/14 (filing for the quarter ended 6/30/2014, filed on 8/14/2014) - less than a one percent increase in common shares outstanding, over the quarter
Total common shares outstanding: 1,660,316,671 as of: 11/14/14 (filing for the most recently reported period, ended 9/30/2014) - less than a two percent increase in common shares outstanding, over the quarter
Total common shares outstanding: 1,660,316,671 as of: 2/9/15 (update provided on the OTCmarkets website) - zero percent increase in common shares outstanding, over the quarter
In the fog of the OTC, some things are truly telling about the essence of a company. As is detailed above, total common shares outstanding for Green Cures has increased by about 2% through more than three fiscal quarters
So here's the objective question I would ask, for those that have had numerous positions in other OTC companies in your trading/investing history. How many of those companies have a similar history of outstanding common share increases as I have detailed above for Green Cures (GRCU)?
As I've opined before, 'Investment wisdom could be defined as the ability to recognize the building of a future empire, even as the earliest bricks are being laid.' I believe those words hold a fundamental truth.
As always, simply my opinion.
GRCU
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM